Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Amorepacific Corporation
  6. News
  7. Summary
    A090430   KR7090430000


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Amorepacific : Develops an Original Technology That Reverses the Aging of Skin Cells in Joint Research with KAIST

11/26/2020 | 08:01pm EDT

SEOUL, South Korea, Nov. 26, 2020 /CNW/ -- Amorepacific R&D Center, together with KAIST, developed an original technology that reverses the aging process in human dermal fibroblasts. The system's biology research was conducted in collaboration with a research team led by Professor Cho Kwang-hyun of the Department of Bio and Brain Engineering at KAIST. The result of the research was published in the online edition of an internationally renowned scientific journal, PNAS, on November 23. (The research article is titled "Inhibition of 3-phosphoinositide–dependent protein kinase 1 (PDK1) can revert cellular senescence in human dermal fibroblasts".)

As skin cells get older, their ability to divide becomes significantly weakened, slowing down the speed of regeneration and the overall functionality of skin tissue. They also lose the ability to produce collagen and elastic fibers which, in turn, slows down skin regeneration making the skin thinner, and thus creating wrinkles. In addition, a weak skin barrier causes frequent dryness, itchy skin, and other troubles.

In this industry-university research collaboration, Amorepacific R&D Center and Professor Cho's team developed a signaling network model for aging skin cells. The joint team ran simulations to analyze the model and discovered a core f that reverses aging in old cells and converts them into younger cells. Using this factor, the team managed to develop an original technology for reverse aging.

These findings are meaningful in that we have found the potential to reverse the biological phenomenon of aging in skin cells that was previously considered irreversible. When we regulated the activity of PDK1 (3-phosphoinositide–dependent protein kinase 1), the core factor that reverse aging, in the artificial model of aged skin, we found that PDK1 inhibition not only reverses the reduction in collagen synthesis, but also helps recover the skin's ability to regenerate. It is expected that we can leverage this reverse aging technology to not only predict and suppress the progress of age-related diseases, but also to prolong the healthy years of our lives.

Park Won-seok, Director of Research & Innovation Center at Amorepacific R&D Center said, "The joint research enabled us to build an aging signal network model and an artificial model for aged skin, with which we saw the potential to reverse the aging process in the skin. Amorepacific will continue to build on our studies on dermatology and bio sector to slow down or improve the progress of aging that was previously thought impossible. We will continue to put in our utmost efforts to safeguard the health of our customers worldwide."

Based on the results of the studies, Amorepacific R&D Center is developing cosmetics that reduce wrinkles by extracting a core ingredient in Camellia japonica seed extract that controls aging in human skin.

View original content to download multimedia:http://www.prnewswire.com/news-releases/amorepacific-develops-an-original-technology-that-reverses-the-aging-of-skin-cells-in-joint-research-with-kaist-301180953.html

SOURCE Amorepacific

© Canada Newswire, source Canada Newswire English

10/04SAMARKAND GROUP PLC : Nomad Checkout Client Win in South Korea
09/17Amorepacific Corporation signed a contract to acquire 38.4% stake in Cosrxinc Co., Ltd...
09/01Amorepacific Corporation acquired Cosvision Corporation from AMOREPACIFIC Group for KRW..
06/02Amorepacific Sets New Sustainability Goals on Palm Oil, Plastics Use
2020AMOREPACIFIC CORPORATION : Ex-dividend day for final dividend
2020AMOREPACIFIC : Develops an Original Technology That Reverses the Aging of Skin Cells in Jo..
2020AMOREPACIFIC : Third-Quarter Net Profit Slid 93%
2020AMOREPACIFIC : Teams Up With China's Largest Travel Retailer CDFG
2020AMOREPACIFIC CORPORATION(KOSE : A090435) added to S&P Global BMI Index
2020AMOREPACIFIC : Publishes Research Paper On Clinical Evaluation Method For Blue Light 456nm..
More news
Sales 2021 4 855 B 4,13 B 4,13 B
Net income 2021 310 B 0,26 B 0,26 B
Net cash 2021 891 B 0,76 B 0,76 B
P/E ratio 2021 37,3x
Yield 2021 0,55%
Capitalization 11 789 B 10 028 M 10 033 M
EV / Sales 2021 2,24x
EV / Sales 2022 1,92x
Nbr of Employees -
Free-Float 54,4%
Duration : Period :
Amorepacific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMOREPACIFIC CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 190 000,00 KRW
Average target price 251 666,67 KRW
Spread / Average Target 32,5%
EPS Revisions
Managers and Directors
Kyung-Bae Suh Chairman & Co-Chief Executive Officer
Se-Hong Ahn Co-Chief Executive Officer & Director
O-Bin Kwon Managing Director & MD-Finance
Jin-Woo Kim MD & MD-Information Technology Division
Jin-Bong Kim Head-Compliance Support
Sector and Competitors
1st jan.Capi. (M$)
L'ORÉAL17.73%236 775
KAO CORPORATION-17.08%27 346
NATURA &CO HOLDING S.A.-17.89%10 763
DCC PLC15.06%8 058